Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.

Also called NCT02280590

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 223 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02280590
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02280590. Randomized; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Condition
Hyperlipidemia
Intervention (Drug)
Rosuvastatin(Cresnon®)
Intervention (Drug)
Rosuvastatin(Crestor®)
Lead sponsor
Dong-A ST Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02280590
Content hash
f1b44d4d223ad1b4d2f92cd63c0d75aa59f6b88de6bf293ca531148ef47cc9d3